![]() ![]() He stressed on more testing, genome surveillance and environmental surveillance in order to track the subvariant and mutations. Drawing a comparison between India and China, Dr Mishra said that India has strong protection of hybrid immunity due to exposure either symptomatic or asymptomatic and China has not developed that situation. SeptemCOVID-19 variants Mu, Delta and what to know about mutations by Deb Balzer Credit: Pixabay/CC0 Public Domain A new COVID-19 variant called B.1621 or mu by the World Health. Its name is B.1617 According to early scientific studies, the new Indian variant would include three mutations in comparison to other strains of the virus. It is like the case with the Omicron variant India went through almost a year back," he said. What is this new variant What can be done to tackle the continuing mutations of the COVID. It means they are vulnerable to the disease. This comes just as India's festive season begins. Millions are unvaccinated or have got only one dose. "And unfortunately, as per the data that is coming in, the senior citizens there are not vaccinated. In China, he further said extensive vaccination was not followed and the vaccine also seemed to be not that effective. But they followed up with a very strong vaccination programme and other preparedness, which China failed," Dr Mishra added. Other countries like Australia and New Zealand also followed strict measures like quarantined and lockdowns. However, people who had symptomatic COVID-19 infection or who died from COVID-19 were more likely to show more NS9b(P10S), N(P13L), NSP12(A97V), and NSP3(T1198K) mutations than patients who were. China has not phased any wave, which means their whole populace is naive. So it is like returning to the disease's beginning in China. ![]() "If I explain the situation in China, they followed the zero COVID policy that did not allow the disease to spread. We have gone through many of these things which for example, China is going through now." Based on all the earlier development of the disease, we are in a very advanced stage compared to them. He said, "We are in very good condition and actually there is nothing to worry about or panic about at this moment. Dr Mishra highlighted that India is in good condition to deal with the situation because of the vaccination coverage and hybrid immunity. He said people should not put down their guards and adhere to COVID protocols like wearing a mask and social distancing. It means the virus will have a good chance to try out new experiments and many variants will emerge from there." Dr Mishra further warned about the new variant and emphasised on genomic surveillance. Now China is the playground for this virus for the next several months. We should be more careful because the only tool this virus has is mutations. That is how it keeps acquiring newer things and keeps giving us surprises once in a while. ![]() Speaking to ANI, Dr Rakesh Mishra, Director, Tata Institute for Genetics and Society said, "They are all sub-variants of Omicron and it is powerful in terms of infectivity. “It is important that surveillance isn’t a start-stop strategy,” she said.By Shalini Bhardwaj New Delhi, December 24 (ANI): Amid the concerns over rising cases of COVID in several countries especially neighbouring China, a top scientist from Tata Institute for Genetics and Society, Bengaluru on Friday said that the COVID subvariant is less likely to trouble India due to hybrid immunity among the populace while adding that people must be careful since the only tool the virus has for an outbreak is mutation. Gagandeep Kang, who studies viruses at India’s Christian Medical College in Vellore, said the growing concern over the variant underlines the need for more sustained efforts to track and trace viruses that combine genetic efforts with real world information about who is getting sick and how badly. It may take several weeks to get a sense of whether the latest Omicron mutant may affect the trajectory of the pandemic. As more people have been vaccinated, boosted or naturally infected, we are starting to see the background levels of immunity worldwide creep up.” “But what we have seen is that the rates of people ending up in the hospital and dying have significantly decreased. “Some may say, ‘Well, vaccination and boosting hasn’t prevented people from getting infected.’ And, yes, that is true,” he said.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |